Travere Therapeutics, Inc.

TVTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 21, 2026 8-K
4 Sep 17, 2026
4 Sep 17, 2026
4 Sep 17, 2026
4 Sep 17, 2026
4 Sep 17, 2026
4 Sep 17, 2026
4 Sep 17, 2026
144 Sep 17, 2026
144 Sep 17, 2026
144 Sep 16, 2026
144 Sep 16, 2026
144 Sep 16, 2026
144 Sep 15, 2026
144 Sep 15, 2026
144 Sep 15, 2026
144 Sep 15, 2026
144 Sep 15, 2026
144 Sep 15, 2026
144 Sep 15, 2026
4 Sep 11, 2026
144 Sep 10, 2026
4 Sep 3, 2026
4 Aug 19, 2026
144 Aug 18, 2026
← Newer Page 1 of 52 · 1281 filings Older →